Having characterized a Tpl2-dependent defect in IL-17A expression, along with the previously identified IFNγ defect, we next examined the capacity of Tpl2−/− T cells to induce disease in a T cell transfer model of colitis associated with a mixed Th1 and Th17 inflammatory response. This evidence concerns the gene IFNG and colitis.